A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program

por Palmieri, Carlo, Musson, Alison, Harper-Wynne, Catherine, Wheatley, Duncan, Bertelli, Gianfilippo, Macpherson, Iain R., Nathan, Mark, McDowall, Ellie, Bhojwani, Ajay, Verrill, Mark, Eva, Joe, Doody, Colm, Chowdhury, Ruhe
Publicado 2023

The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience

por Crolley, Valerie E., Marashi, Husam, Rawther, Shabbir, Sirohi, Bhawna, Parton, Marina, Graham, Janine, Vinayan, Anup, Sutherland, Stephanie, Rigg, Anne, Wadhawan, Anshu, Harper-Wynne, Catherine, Spurrell, Emma, Bond, Hannah, Raja, Fharat, King, Judy
Publicado 2020

Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast canc...

por El Badri, Salma, Tahir, Bilal, Balachandran, Kirsty, Bezecny, Pavel, Britton, Fiona, Davies, Mark, Desouza, Karen, Dixon, Simon, Hills, Daniel, Moe, Maung, Pigott, Thomas, Proctor, Andrew, Shah, Yatri, Simcock, Richard, Stansfeld, Anna, Synowiec, Alicja, Theodoulou, Marianna, Verrill, Mark, Wadhawan, Anshu, Harper-Wynne, Catherine, Wilson, Caroline
Publicado 2021

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Cli...

por Schmid, Peter, Zaiss, Matthias, Harper-Wynne, Catherine, Ferreira, Marta, Dubey, Sidharth, Chan, Stephen, Makris, Andreas, Nemsadze, Gia, Brunt, Adrian M., Kuemmel, Sherko, Ruiz, Isabel, Perelló, Antonia, Kendall, Anne, Brown, Janet, Kristeleit, Hartmut, Conibear, John, Saura, Cristina, Grenier, Julien, Máhr, Károly, Schenker, Michael, Sohn, Joohyuk, Lee, Keun Seok, Shepherd, Christopher J., Oelmann, Elisabeth, Sarker, Shah-Jalal, Prendergast, Aaron, Marosics, Patricia, Moosa, Atiyyah, Lawrence, Cheryl, Coetzee, Carike, Mousa, Kelly, Cortés, Javier
Publicado 2019

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

por Lee, Lennard Y W, Starkey, Thomas, Ionescu, Maria C, Little, Martin, Tilby, Michael, Tripathy, Arvind R, Mckenzie, Hayley S, Al-Hajji, Youssra, Barnard, Matthew, Benny, Liza, Burnett, Alexander, Cattell, Emma L, Charman, Jackie, Clark, James J, Khan, Sam, Ghafoor, Qamar, Illsley, George, Harper-Wynne, Catherine, Hattersley, Rosie J, Lee, Alvin J X, Leonard, Pauline C, Liu, Justin K H, Pang, Matthew, Pascoe, Jennifer S, Platt, James R, Potter, Vanessa A, Randle, Amelia, Rigg, Anne S, Robinson, Tim M, Roques, Tom W, Roux, René L, Rozmanowski, Stefan, Tuthill, Mark H, Watts, Isabella, Williams, Sarah, Iveson, Tim, Lee, Siow Ming, Middleton, Gary, Middleton, Mark, Protheroe, Andrew, Fittall, Matthew W, Fowler, Tom, Johnson, Peter
Publicado 2022

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study

por Lee, Lennard Y.W., Ionescu, Maria C., Starkey, Thomas, Little, Martin, Tilby, Michael, Tripathy, Arvind R., Mckenzie, Hayley S., Al-Hajji, Youssra, Appanna, Nathan, Barnard, Matthew, Benny, Liza, Burnett, Alexander, Cattell, Emma L., Clark, James J., Khan, Sam, Ghafoor, Qamar, Panneerselvam, Hari, Illsley, George, Harper-Wynne, Catherine, Hattersley, Rosie J., Lee, Alvin JX., Lomas, Oliver, Liu, Justin KH., McCauley, Amanda, Pang, Matthew, Pascoe, Jennifer S., Platt, James R., Patel, Grisma, Patel, Vijay, Potter, Vanessa A., Randle, Amelia, Rigg, Anne S., Robinson, Tim M., Roques, Tom W., Roux, René L., Rozmanowski, Stefan, Taylor, Harriet, Tuthill, Mark H., Watts, Isabella, Williams, Sarah, Beggs, Andrew, Iveson, Tim, Lee, Siow M., Middleton, Gary, Middleton, Mark, Protheroe, Andrew, Fittall, Matthew W., Fowler, Tom, Johnson, Peter
Publicado 2022

A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)

por Starkey, Thomas, Ionescu, Maria C., Tilby, Michael, Little, Martin, Burke, Emma, Fittall, Matthew W., Khan, Sam, Liu, Justin K. H., Platt, James R., Mew, Rosie, Tripathy, Arvind R., Watts, Isabella, Williams, Sophie Therese, Appanna, Nathan, Al-Hajji, Youssra, Barnard, Matthew, Benny, Liza, Burnett, Alexander, Bytyci, Jola, Cattell, Emma L., Cheng, Vinton, Clark, James J., Eastlake, Leonie, Gerrand, Kate, Ghafoor, Qamar, Grumett, Simon, Harper-Wynne, Catherine, Kahn, Rachel, Lee, Alvin J. X., Lomas, Oliver, Lydon, Anna, Mckenzie, Hayley, Panneerselvam, Hari, Pascoe, Jennifer S., Patel, Grisma, Patel, Vijay, Potter, Vanessa A., Randle, Amelia, Rigg, Anne S., Robinson, Tim M., Roylance, Rebecca, Roques, Tom W., Rozmanowski, Stefan, Roux, René L., Shah, Ketan, Sheehan, Remarez, Sintler, Martin, Swarup, Sanskriti, Taylor, Harriet, Tillett, Tania, Tuthill, Mark, Williams, Sarah, Ying, Yuxin, Beggs, Andrew, Iveson, Tim, Lee, Siow Ming, Middleton, Gary, Middleton, Mark, Protheroe, Andrew, Fowler, Tom, Johnson, Peter, Lee, Lennard Y. W.
Publicado 2023